Immune checkpoint inhibitors have transformed cancer treatment, but their immune-mediated effects can also lead to important cardiovascular complications. In this recorded expert session, specialists in oncology and cardiology discuss the mechanisms behind these toxicities, how to recognise patients at risk, and which warning signs deserve particular attention. The session also covers practical approaches to diagnosis, monitoring and management, with a strong focus on multidisciplinary collaboration in everyday clinical practice.

Watch the session to gain practical insights into recognising and managing cardiovascular toxicity associated with immune checkpoint inhibitors.

FACULTY
Dr Cleo Bertels, UZ Brussel
Prof Constantijn Franssen, UZA
Dr Delphine Vervloet, AZ Maria Middelares



Register via the form on the right to get free access to the videos. 👉